首页 › 胶质瘤 › 哥伦比亚特区 › Washington
Washington DC 胶质瘤临床试验
19项针对 胶质瘤的研究正在 Washington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
招募中1/2 期
- Children's National Medical Center, Washington D.C.
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
招募中2 期
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
招募中2 期
- Children's National Medical Center, Washington D.C.
NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
招募中1 期
- Children's National Hospital, Washington D.C.
Targeted Pediatric High-Grade Glioma Therapy
招募中观察性研究
- Children's National Medical Center, Washington D.C.
Study of Olutasidenib and Temozolomide in HGG
招募中2 期
- Children's National Medical Center, Washington D.C.
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
招募中2 期
- Children's National Medical Center, Washington D.C.
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
招募中1 期
- Children's National Medical Center, Washington D.C.
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
招募中1 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
招募中1/2 期
- National Institutes of Health Clinical Center, Bethesda · 距离 7 英里
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
招募中1/2 期
- Children's National Hospital, Washington D.C.
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
招募中早期 I 期欢迎健康志愿者
- Children's National Medical Center, Washington D.C.
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
招募中1 期
- Children's National Hospital, Washington D.C.
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
招募中2 期
- Children's National Medical Center, Washington D.C.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
招募中1/2 期
- Sibley Memorial Hospital, Washington D.C.
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
招募中早期 I 期
- Children's National Medical Center, Washington D.C.
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
招募中1 期
- National Institutes of Health, Bethesda · 距离 7 英里
其他城市的 胶质瘤试验
- New York City, NY25 项研究
- Houston, TX23 项研究
- Boston, MA20 项研究
- Philadelphia, PA16 项研究
- Columbus, OH15 项研究
- Miami, FL15 项研究
- San Francisco, CA14 项研究
- Chicago, IL13 项研究
- Durham, NC12 项研究
- Seattle, WA11 项研究
- St. Louis, MO10 项研究
- Aurora, CO10 项研究
Washington的其他研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌55 项研究
- 乳腺癌46 项研究
- 转移性癌症43 项研究
- 肺癌41 项研究
- 前列腺癌38 项研究
- 肥胖症33 项研究
- 结直肠癌29 项研究
- 心血管疾病28 项研究
- 膀胱癌26 项研究
- 急性髓系白血病24 项研究
- 卵巢癌23 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。